Michiko Shikano
Overview
Explore the profile of Michiko Shikano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamiya T, Fukuta H, Hagiwara H, Shikano M, Kato T, Imaeda K
J Smooth Muscle Res
. 2022 Feb;
58(0):1-10.
PMID: 35173105
Purpose: Gastric dysmotility has been reported in patients with long-standing diabetes mellitus (DM). Some patients with DM are diagnosed as diabetes gastroparesis and have several upper gastrointestinal (GI) symptoms such...
2.
Kamiya T, Shikano M, Kubota E, Mizoshita T, Wada T, Tanida S, et al.
J Clin Biochem Nutr
. 2017 Apr;
60(2):130-135.
PMID: 28366993
The aims of this study were to compare the therapeutic effects of a proton pump inhibitor (PPI), rabeprazole (RPZ), and a prokinetic agent, itopride (ITO), and to investigate the role...
3.
Kimura Y, Kamiya T, Senoo K, Tsuchida K, Hirano A, Kojima H, et al.
J Clin Biochem Nutr
. 2016 Aug;
59(1):71-7.
PMID: 27499583
Some patients with gastroesophageal reflux disease experience persistent reflux symptoms despite proton pump inhibitor therapy. These symptoms reduce their health-related quality of life. Our aims were to evaluate the relationship...
4.
Kamiya T, Shikano M, Tanaka M, Ozeki K, Ebi M, Katano T, et al.
Evid Based Complement Alternat Med
. 2014 Aug;
2014:828137.
PMID: 25161692
Background. Recently, it was revealed that low grade mucosal inflammation and/or immune imbalance of the lower digestive tract is one of the mechanisms involved in symptom generation in patients with...
5.
Kamiya T, Shikano M, Tanaka M, Tsukamoto H, Ebi M, Hirata Y, et al.
J Smooth Muscle Res
. 2011 Oct;
47(3-4):79-87.
PMID: 21979407
Omeprazole, a proton pump inhibitor, is widely used for the treatment of patients with peptic ulcer, gastroesophageal reflux disease and functional dyspepsia (FD), although some studies have demonstrated that omeprazole...
6.
Ueda T, Shikano M, Kamiya T, Joh T, Ugawa S
Am J Physiol Gastrointest Liver Physiol
. 2011 Apr;
301(1):G138-47.
PMID: 21493730
The esophageal epithelium has sensory properties that enable it to sustain normal barrier function. Transient receptor potential vanilloid 4 (TRPV4) is a Ca(2+)-permeable channel that is activated by extracellular hypotonicity,...
7.
Hondoh A, Ishida Y, Ugawa S, Ueda T, Shibata Y, Yamada T, et al.
Brain Res
. 2010 Jan;
1319:60-9.
PMID: 20079339
TRPM8 and TRPA1 are cold-activated transient receptor potential (TRP) cation channels. TRPM8 is activated by moderate cooling, while TRPA1 is activated by extreme, noxious cold temperatures. These cold receptors are...
8.
Kamiya T, Adachi H, Hirako M, Shikano M, Matsuhisa E, Wada T, et al.
J Gastroenterol
. 2009 Feb;
44(3):183-9.
PMID: 19214661
Background: More than half of patients with refluxrelated symptoms have no endoscopic evidence of mucosal breaks. These patients are considered to have nonerosive gastroesophageal reflux disease (NERD). The pathogenesis of...
9.
Kamiya T, Shikano M, Wada T, Sasaki M, Joh T
Nihon Rinsho
. 2008 Jul;
66(7):1385-90.
PMID: 18616132
Probiotics are live microbial feed supplement which beneficially affects the host animals by improving its microbial balance. Probiotics have been used in the treatment of bacterial or viral induced acute...
10.
Adachi H, Kamiya T, Hirako M, Misu N, Kobayashi Y, Shikano M, et al.
J Smooth Muscle Res
. 2007 Dec;
43(5):179-89.
PMID: 18075227
Background: Gastrointestinal (GI) symptoms are common in patients with chronic renal failure (CRF). We have previously demonstrated that patients with predialysis end-stage renal disease showed a high prevalence of GI...